ATACH-2

いつでもどこでも、お使いの端末で何百万もの最新の Android アプリ、ゲーム、音楽、映画、テレビ番組、書籍、雑誌などをお楽しみください。

This mobile application was created to facilitate enrollment into the ATACH-II Clinical Trial. ATACH-II is a five-year clinical trial designed to determine the efficacy of early, intensive antihypertensive treatment in stroke patients.

The primary hypothesis of this trial is that treating hemorrhagic stoke survivors with intensive blood pressure reduction therapy will reduce the proportion of death and disability at 3 months by 10% or greater compared with the group treated with the standard blood pressure reduction therapy.